Prof. Dr. Daniel Boll

The structured assessment of disease and subsequent quantification of relevant lesions leads to an effective and reproducible therapy response evaluation.

Related Resources

Related Resources

Participants at the RECIST and Beyond workshop in Cologne during hands-on training with mint Lesion for structured tumor response assessment.

Successful “RECIST and Beyond” Workshop in Cologne: Advancing Precision in Oncologic Imaging

How can complex tumor findings be assessed accurately, reproducibly, and in line with clinical guidelines?

RSNA 2025

11/30 to 12/03/2025 Chicago, Illinois

Annual Meeting of the Radiological Society of North America

Screenshot of the mint Lesion interface showing RANO 2.0 configuration, tumor burden calculations, and structured neuro-oncology assessment tools.

Implementing RANO 2.0 for Neuro-Oncology Clinical Trials in mint Lesion

Tumor response assessment in neuro-oncology clinical trials requires careful attention to measurement protocols and confirmation scan requirements. To…